La Nuvola, Rome, Italy
May 21-25, 2023
Roma 2023 – Wordlab-Euromedlab (




Shimadzu is a world-leading manufacturer of analytical instrumentation. We develop and manufacture innovative products for laboratories in industry, science and governmental institutions.

We believe that innovation can improve people’s health and healthcare outcomes.

Our research and development programs are applied to a range of diverse technologies including diagnostic X-ray imaging, positron emission tomography (PET) dedicated for breast cancer to mass spectrometry based platforms like MALDI for routine clinical microbiology, PESI applied to cancer screening in tissue and serum, LC-MS/MS for routine clinical toxicology analysis. At Shimadzu, our purpose is to bring meaningful innovation to what we do, bringing about change. With our MALDI systems we have changed the way in a blood-based approach is used in amyloid-beta analysis for helping to screen neurodegenerative disease. With our CLAM-LC-MS/MS we were the first to change the way in which routine clinical samples could be analyzed.




Waiting for confirmation



Sponsored Lecture

SATELLITE MEETING - Clinical mass spectrometry: validation and accreditation of IVD and Laboratory Developed Test (LDT) in the new Regulation EU 2017/746 era
organized by SIBioC & SGKC

La Nuvola, Roma, Italy
May 20-21, 2023


Saturday, 20.05.2023
17 - 17:30 h
Title: Automated solution for high-throughput immunosuppressants TDM

Speaker: Mikael LEVI | Alsachim (France)


Product Lineup

Please contact us during the conference to get more information for the following instruments and solutions:


Automated Immunosuppresants analysis by LCMS (IVD)


Research & Innovation

To keep our high standard and develop new technologies through collaborations with cutting-edge researchers, Shimadzu established in 2017 the European innovation Center - and innovation-oriented Think Tank - focusing on clinical research.


Amyloid blood test for Alzheimer disease


Top of This Page